NCT02016729 2019-02-27A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid LeukemiaKartos Therapeutics, Inc.Phase 1 Completed36 enrolled
NCT00920140 2014-04-02Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory LeukemiasGlaxoSmithKlinePhase 2 Completed97 enrolled 23 charts